Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 28
Filter
Add more filters











Publication year range
1.
Pak J Pharm Sci ; 30(5): 1545-1550, 2017 Sep.
Article in English | MEDLINE | ID: mdl-29084671

ABSTRACT

Glutamate decarboxylase or glutamic acid decarboxylase (GAD) is a protein associated with autoimmune diseases, including type-1 diabetes. This disease is primarily associated with the occurrence of a specific isoform: GAD65. Conversely, some specific peptides of this protein may block autoimmunity in diabetes. In this respect, understanding the relationship between GAD and the development of diabetes is important, and it is necessary to understand the role of each GAD peptide to design effective autoimmune diabetes treatments. The purpose of the present study was to analyze the effects of treatment with GAD-derived peptides p217 and p290 on INS receptors in the salivary epithelium of nonobese diabetic (NOD) animals. Three groups of 7 mice each were studied: I, BALB/c mice (control); II, NOD mice; and III, NOD mice treated with peptides p290 and p217. Groups I and II only received buffered saline solution. Glucose levels were measured daily during the 21 days of the experiment. After the study, the animals were euthanized and the parotid and submandibular glands were removed for the analysis of INS-R by fluorescence microscopy. Therapy with two peptides together was associated with reduced glucose levels in NOD mice and intense INS-R expression in both salivary organs. Our approach of combining GAD p217 and p290 peptides contributed to hormonal balance and promoted the repair of INS-R.


Subject(s)
Diabetes Mellitus, Type 1/drug therapy , Epithelial Cells/drug effects , Glutamate Decarboxylase/metabolism , Hypoglycemic Agents/pharmacology , Parotid Gland/drug effects , Peptide Fragments/pharmacology , Receptor, Insulin/metabolism , Submandibular Gland/drug effects , Animals , Biomarkers/blood , Blood Glucose/drug effects , Blood Glucose/metabolism , Diabetes Mellitus, Type 1/blood , Diabetes Mellitus, Type 1/enzymology , Diabetes Mellitus, Type 1/pathology , Disease Models, Animal , Epithelial Cells/enzymology , Epithelial Cells/pathology , Female , Mice, Inbred BALB C , Mice, Inbred NOD , Parotid Gland/enzymology , Parotid Gland/pathology , Submandibular Gland/enzymology , Submandibular Gland/pathology
2.
Oxid Med Cell Longev ; 2013: 674593, 2013.
Article in English | MEDLINE | ID: mdl-23738039

ABSTRACT

Many studies suggest that fluoride exposure can inhibit the activity of various enzymes and can generate free radicals, which interfere with antioxidant defence mechanisms in living systems. To further the understanding of this issue, this present study examined the effects of low-dose fluoride treatment on the activity of enzymatic antioxidant superoxide dismutase (SOD) and catalase (CAT), as well as the levels of lipid peroxidation (LPO) in the parotid (PA) and submandibular (SM) salivary glands of rats. Rats were injected with a single dose of sodium fluoride (NaF) (15 mg F(-)/kg b.w.) then euthanized at various time intervals up to 24 hours (h) following exposure. NaF exposure did not cause significant differences in SOD or CAT activity or LPO levels in PA glands compared to control. Conversely, SM glands presented increased SOD activity after 3 h and decreased SOD activity after 1, 12, and 24 h, while LPO was increased after 6, 12, and 24 h of the NaF injection. There were no significant differences in the CAT activity in the groups studied. Our results demonstrated that NaF intoxication caused oxidative stress in salivary glands few hours after administration. These changes were more pronounced in SM than in PA gland.


Subject(s)
Antioxidants/metabolism , Lipid Peroxidation/drug effects , Salivary Glands/enzymology , Sodium Fluoride/pharmacology , Animals , Catalase/metabolism , Male , Malondialdehyde/metabolism , Parotid Gland/drug effects , Parotid Gland/enzymology , Rats , Rats, Wistar , Salivary Glands/drug effects , Submandibular Gland/drug effects , Submandibular Gland/enzymology , Superoxide Dismutase/metabolism
3.
Arch Oral Biol ; 56(12): 1514-20, 2011 Dec.
Article in English | MEDLINE | ID: mdl-21741619

ABSTRACT

OBJECTIVE: In a previous study we observed that parotid glands from rats with experimental periodontitis showed an increase in basal amylase release as a result of an increase in cAMP accumulation induced by PGE(2) production. The aim of this work was to study whether this change in amylase release influences the secretory effect of carbachol. DESIGN: Experimental periodontitis was induced through placing a black thread around the cervix of the two lower first molars. Experiments were done 22 days after ligature induced periodontitis. Amylase release was evaluated in vitro and determined using a colorimetric method which uses starch as substrate. RESULTS: The effect of carbachol was increased in parotid glands from periodontitis rats. The effect of 10(-6)M carbachol was inhibited by 4-DAMP (10(-6)M), U-73122 (5 × 10(-6)M) and trifluoperazine (5 × 10(-6)M) in both groups. No changes were observed in the binding sites and affinity in parotid membranes from rats with experimental periodontitis. The inhibition of the adenylyl cyclase and the cyclooxygenase induced a right shift of the carbachol concentration-response curve in periodontitis group whilst the opposite effect was observed in control group in the presence of db-cAMP and PGE(2). CONCLUSIONS: Parotid glands from rats with experimental periodontitis release more amylase in response to carbachol suggesting an interaction between Ca(2+) and cAMP in the fusion/exocytosis step of secretory vesicles.


Subject(s)
Amylases/biosynthesis , Carbachol/pharmacology , Enzyme Activation/drug effects , Parotid Gland/enzymology , Periodontitis/enzymology , Analysis of Variance , Animals , Colorimetry/methods , Cyclic AMP/physiology , Male , Parotid Gland/drug effects , Periodontitis/metabolism , Rats , Rats, Wistar
4.
Oral Dis ; 16(8): 801-6, 2010 Nov.
Article in English | MEDLINE | ID: mdl-20561219

ABSTRACT

OBJECTIVE: In this study we investigated the activity of the nitric oxide synthase (NOS) in parotid glands from rats with experimental periodontitis and controls. METHODS: Periodontitis was produced by a ligature placed around the cervix of the two lower first molar. Experiments were carried out 22 days after the ligature. RESULTS: Ligation caused an increase in parotid NOS activity. The selective blocker of the inducible isoform of the enzyme partially inhibited its activity in parotid glands from rat with ligature. In controls, the activity was partially inhibited by the antagonists of the selective neural and endothelial isoforms. NOS activity in rats with ligature was cyclic adenosine monophosphate (cAMP)-dependent while in controls it was calcium-dependent. Prostaglandin E2 concentration was increased in parotid gland from rats with ligature. The inhibitor of prostaglandin production, FR 122047, diminished both, prostaglandin production and NOS activity. In rats with ligature unstimulated amylase released is increased. Both, prostaglandin and NOS were involved in the increment of amylase release. CONCLUSION: It can be concluded that in parotid glands from ligated rats, prostaglandin E2 production is increased and, through cAMP accumulation, activates the inducible NOS isoform. The increment of nitric oxide production participates in the increase in basal amylase release.


Subject(s)
Nitric Oxide Synthase/metabolism , Parotid Gland/enzymology , Periodontitis/enzymology , Salivary Proteins and Peptides/metabolism , Adenine/analogs & derivatives , Adenine/pharmacology , Amylases/metabolism , Animals , Calcium/pharmacology , Cyclic AMP-Dependent Protein Kinase Catalytic Subunits/antagonists & inhibitors , Cyclic AMP-Dependent Protein Kinase Catalytic Subunits/pharmacology , Cyclooxygenase Inhibitors/pharmacology , Dinoprostone/antagonists & inhibitors , Dinoprostone/metabolism , Disease Models, Animal , Egtazic Acid/pharmacology , Enzyme Inhibitors/pharmacology , Guanidines/pharmacology , Indazoles/pharmacology , Indomethacin/pharmacology , Male , Nitric Oxide Synthase/antagonists & inhibitors , Nitric Oxide Synthase Type I/antagonists & inhibitors , Nitric Oxide Synthase Type II/antagonists & inhibitors , Nitric Oxide Synthase Type III/antagonists & inhibitors , Organ Size , Ornithine/analogs & derivatives , Ornithine/pharmacology , Parotid Gland/drug effects , Piperazines/pharmacology , Prostaglandin-Endoperoxide Synthases/drug effects , Rats , Rats, Wistar , Salivary Proteins and Peptides/drug effects , Thiazoles/pharmacology , omega-N-Methylarginine/pharmacology
5.
Inflammation ; 32(6): 357-63, 2009 Dec.
Article in English | MEDLINE | ID: mdl-19669869

ABSTRACT

It is known that subjects with periodontitis show enhanced amylase concentration in saliva. Our purpose was to analyze the release of amylase in parotid glands from rats with experimental periodontitis and controls. We present evidence that periodontitis induces an increase in resting amylase activity and release without changes in isoproterenol-induced amylase secretion. Changes in amylase were reverted by the inhibition of the adenylyl cyclase by SQ 22536, the cyclooxygenase type 1 by FR 122047 and by blocking the vasoactive intestinal peptide (VIP) receptor with VIP 6-28. Parotid glands from rats with periodontitis showed an increase in cAMP levels that was also reverted in the presence of SQ 22536, FR 122047 and VIP 6-28. We concluded that both PGE(2) and VIP are produced in parotid glands from rats with periodontitis and, by activating their own receptors in acinar cells, induce cAMP accumulation leading to an increase in amylase basal secretion.


Subject(s)
Amylases/biosynthesis , Cyclic AMP/physiology , Parotid Gland/enzymology , Periodontitis/enzymology , Amylases/metabolism , Animals , Enzyme Activation/drug effects , Enzyme Activation/physiology , Isoproterenol/pharmacology , Male , Parotid Gland/drug effects , Parotid Gland/pathology , Periodontitis/metabolism , Periodontitis/pathology , Rats , Rats, Wistar
6.
Cell Biochem Funct ; 27(3): 128-34, 2009 Apr.
Article in English | MEDLINE | ID: mdl-19274685

ABSTRACT

Diabetes has been implicated in the dryness of the mouth, loss of taste sensation, sialosis, and other disorders of the oral cavity, by impairment of the salivary glands. The aim of the present study was to examine the plasma membrane, microsomal, and homogenate Ca(2+)-ATPase activity in the rat submandibular and parotid salivary glands of streptozotocin-induced diabetes. We have also examined the influence of the acidosis state on this parameter. Diabetes was induced by an intraperitoneal injection of streptozotocin and acidosis was induced by daily injection of NH(4)Cl. At 15 and 30 days after diabetes induction, the animals were euthanized and the submandibular and parotid salivary glands were removed and analyzed. Ca(2+)-ATPase (total, independent, and dependent) was determined in the homogenate, microsomal, and plasma membranes of the salivary glands of diabetic and control rats. Calcium concentration was also determined in the glands and showed to be higher in the diabetic animals. Ca(2+)-ATPase activity was found to be reduced in all cell fractions studied in the diabetic animals compared with control. Similar results were obtained for the submandibular salivary glands of acidotic animals; however in the parotid salivary glands it was found an increase in the enzyme activity.


Subject(s)
Calcium-Transporting ATPases/metabolism , Cell Membrane/enzymology , Diabetes Mellitus, Experimental/enzymology , Microsomes/enzymology , Salivary Glands/cytology , Salivary Glands/enzymology , Acidosis/complications , Acidosis/enzymology , Animals , Calcium/metabolism , Diabetes Mellitus, Experimental/complications , Male , Parotid Gland/enzymology , Rats , Rats, Wistar , Subcellular Fractions/enzymology , Submandibular Gland/enzymology
7.
Lasers Med Sci ; 24(4): 591-6, 2009 Jul.
Article in English | MEDLINE | ID: mdl-18982402

ABSTRACT

The aim of this study was to evaluate the effect of laser irradiation (LI) on enzymatic activities of amylase, catalase and peroxidase in the parotid glands (PG) of diabetic and non-diabetic rats. Ninety-six female rats were divided into eight groups: D0; D5; D10; D20 and C0; C5; C10; C20, respectively. Diabetes was induced by administration of streptozotocin and confirmed later by the glycemia results. Twenty-nine (29) days after the induction, the PGs of groups D5 and C5; D10 and C10; D20 and C20, were irradiated with 5 J/cm(2), 10 J/cm(2) and 20 J/cm(2) of laser diode (660 nm/100 mW) respectively. On the following day, the rats were euthanized and the enzymatic activity in the PGs was measured. Diabetic rats that had not been irradiated (group D0) showed higher catalase activity (P < 0.05) than those in group C0 (0.14 +/- 0.02 U/mg protein and 0.10 +/- 0.03 U/mg protein, respectively). However, laser irradiation of 5 J/cm(2) and 20 J/cm(2) decreased the catalase activity of the diabetic groups (D5 and D20) to non-diabetic values (P > 0.05). Based on the results of this study, LI decreased catalase activity in the PGs of diabetic rats.


Subject(s)
Diabetes Mellitus, Experimental/enzymology , Diabetes Mellitus, Experimental/radiotherapy , Lasers, Semiconductor/therapeutic use , Low-Level Light Therapy , Parotid Gland/enzymology , Parotid Gland/radiation effects , Amylases/metabolism , Animals , Catalase/metabolism , Diabetes Complications/enzymology , Diabetes Complications/etiology , Female , Humans , Peroxidase/metabolism , Rats , Rats, Wistar , Xerostomia/enzymology , Xerostomia/etiology , Xerostomia/radiotherapy
8.
Pediatr Res ; 61(2): 203-8, 2007 Feb.
Article in English | MEDLINE | ID: mdl-17237723

ABSTRACT

Infantile chronic recurrent parotitis (ICRP) is an insidious disease whose etiopathogenesis remains an enigma. Alterations in the physical appearance of parotid saliva from ICRP patients have been frequently reported. However, sialochemical studies in regard to ICRP are very rare. The aim of this study was to determine whether saliva of ICRP patients presents major physicochemical and biochemical alterations compared with saliva from paired healthy controls. Parotid, whole, and submandibular/sublingual saliva was collected at an asymptomatic stage from 33 ICRP patients (5-16 y old, both sexes) and from 33 sex- and age-matched healthy controls. Saliva was analyzed for protein concentration, mode of protein diffusion on cellulose membranes, unidimensional sodium dodecylsulfate (SDS)-polyacrylamide gel electrophoresis protein profiles and zymographic profiles of metalloproteinase 2 (MMP-2) and metalloproteinase 9 (MMP-9). Parotid saliva of ICRP patients showed an increased protein concentration, altered mode of protein diffusion, a higher frequency of polypeptide bands of 43, 37, 33, 29, 26, 16, and 10 kD, higher asymmetry in the polypeptide profiles of both contralateral parotid saliva, and an increase in the frequency of MMP-2 and MMP-9. Parotid saliva of patients with ICRP is molecularly altered with respect to normal saliva. Some of the molecular differences could be related to the etiopathogenesis of the disease.


Subject(s)
Parotitis/metabolism , Saliva/metabolism , Salivary Proteins and Peptides/metabolism , Adolescent , Child , Child, Preschool , Chronic Disease , Female , Humans , Male , Matrix Metalloproteinase 2/metabolism , Matrix Metalloproteinase 9/metabolism , Parotid Gland/chemistry , Parotid Gland/enzymology , Parotitis/enzymology , Parotitis/pathology , Recurrence , Saliva/chemistry
9.
Braz Oral Res ; 20(2): 108-13, 2006.
Article in English | MEDLINE | ID: mdl-16878202

ABSTRACT

Although the influence of diabetes on salivary glands is well studied, it still presents conflicting results. In this work, the regulation of the phosphofructokinase-1 enzyme (PFK-1) was studied utilizing the salivary glands of rats. Diabetes was induced by a single intraperitoneal injection of streptozotocin (60 mg/Kg of body weight) in rats (180-200 g). The animals were killed 30 days after the induction of diabetes and the submandibular and parotid salivary glands were used. Hyperglycemia was evaluated by blood sugar determination. The distribution of PFK-1 between the soluble and cytoskeleton fractions, the phosphate content of PFK-1, the content of fructose-2,6-bisphosphate and the activity of the PFK-2 enzyme were determined. The calculated relative glandular weight showed a higher value for the parotid gland in comparison with the control, but not for the submandibular gland. The activity of PFK-1 expressed per gland showed no variation between diabetic and control animals. However, considering the specific activity, the soluble enzyme presented a value 50% higher than that of the control and the cytoskeleton bound form increased by 84% compared to the control. For the parotid gland, no difference in the specific activity between diabetic and control animals was observed. On the other hand, the activity per gland of the soluble enzyme increased in the diabetic animals. The phosphate content of PFK-1 increased in the submandibular and parotid glands of diabetic rats. Both the content of fructose-2,6-bisphosphate and the active form of PFK-2 were reduced in the diabetic glands. In conclusion, the increase in the activity of PFK-1 observed in the salivary glands of rats with streptozotocin-induced diabetes does not seem to be due to its modulator fructose-2,6-bisphosphate.


Subject(s)
Diabetes Mellitus, Experimental/enzymology , Phosphofructokinase-1/metabolism , Salivary Glands/enzymology , Animals , Cytoskeleton/enzymology , Diabetes Mellitus, Experimental/chemically induced , Male , Parotid Gland/enzymology , Phosphofructokinase-1/analysis , Rats , Rats, Wistar , Streptozocin , Submandibular Gland/enzymology
10.
Braz. oral res ; 20(2): 108-113, Apr.-June 2006. tab
Article in English | LILACS | ID: lil-432185

ABSTRACT

Apesar de existirem muitos estudos sobre a influência do diabetes nas glândulas salivares, esses apresentam resultados conflitantes. Neste estudo, a regulação da enzima fosfofrutoquinase-1 (PFK-1) foi estudada utilizando-se glândulas salivares de ratos. O diabetes foi induzido por uma única injeção intraperitonial de estreptozotocina (60 mg/kg peso corporal) em ratos (180-200 g). Os animais foram sacrificados 30 dias após a indução do diabetes e utilizaram-se as glândulas submandibular e parótida. A hiperglicemia foi avaliada por determinação da glicemia sanguínea. A distribuição da PFK-1 entre frações solúvel e ligada, concentração de fosfato na PFK-1, concentração de frutose-2,6-bisfosfato e a atividade da enzima PFK-2 foram determinadas. O cálculo do peso glandular relativo mostrou um aumento na glândula parótida de ratos diabéticos comparados ao controle, o que não ocorreu na glândula submandibular. A atividade da PFK-1 expressa por glândula não mostrou variação entre animais diabético e controle. Contudo, considerando a atividade específica, a fração solúvel da enzima mostrou aumento de 50% com relação ao controle e a fração ligada ao citoesqueleto um aumento de 84% com relação ao controle. Na glândula parótida não foi observada diferença na atividade específica entre os grupos diabético e controle. Por outro lado, a atividade por glândula da fração solúvel aumentou nos animais diabéticos. A concentração de fosfato da PFK-1 aumentou nas glândulas submandibular e parótida nos animais diabéticos. Tanto a concentração de frutose-2,6-bisfosfato quanto a forma ativa da PFK-2 mostraram redução nas glândulas salivares. Concluindo, o aumento na atividade da PFK-1 observado nas glândulas salivares de ratos com diabetes induzida por estreptozotocina não parece ser modulado pela frutose-2,6-bisfosfato.


Subject(s)
Animals , Male , Rats , Diabetes Mellitus, Experimental/enzymology , Phosphofructokinase-1/metabolism , Salivary Glands/enzymology , Cytoskeleton/enzymology , Diabetes Mellitus, Experimental/chemically induced , Parotid Gland/enzymology , Phosphofructokinase-1/analysis , Rats, Wistar , Streptozocin , Submandibular Gland/enzymology
11.
Acta Physiol (Oxf) ; 186(1): 29-36, 2006 Jan.
Article in English | MEDLINE | ID: mdl-16497177

ABSTRACT

AIM: In this study, we have determined signalling pathways involved in adenosine A(1) receptor (A(1) receptor)-dependent stimulation of amylase release in rat parotid gland. METHODS: Amylase release, binding and cyclic adenosine monophosphate (cAMP) assays, inositol phosphates (IPs) production and nitric oxide synthase (NOS) activity in the presence of cyclopentyl-1,3-dipropylxanthine (CPA) alone or in the presence of different inhibitory drugs were performed. RESULTS: The binding parameters of specific A(1) antagonist [(3)H]-cyclopentyl 1,3-dipropilxanthine ([(3)H]-DPCPX) in parotid gland membranes show a population of high affinity sites with K(d) (nm) 0.53 +/- 0.06 and B(max) (fmol mg(-1) protein) 122.6 +/- 10.2. CPA stimulation of A(1) receptor exerts an increase in amylase release, IPs accumulation, cAMP production and NOS activity. All these A(1) agonist effects were blocked by the A(1) receptor antagonist DPCPX. Inhibitors of phospholipase C (PLC), calcium/calmodulin (CaM), protein kinase C (PKC), and adenylate cyclase, but not NOS, activities attenuated the CPA stimulatory effect on amylase release. The effect of CPA on amylase release significantly correlated with its action either on cAMP or on IPs accumulation. CONCLUSION: These results suggest that CPA activation of parotid gland A(1) receptor induces a stimulatory effect on amylase release associated with increased production of cAMP and IPs accumulation. The mechanism appears to occur secondarily to stimulation of phosphoinositide turnover via PLC activation. This, in turn, triggers cascade reactions involving CaM and PKC. The CPA stimulation of NOS does not appear to participate in amylase release.


Subject(s)
Amylases/metabolism , Parotid Gland/physiology , Receptor, Adenosine A1/physiology , Signal Transduction/physiology , Adenosine A1 Receptor Antagonists , Animals , Calcium/metabolism , Cyclic AMP/analysis , Female , Inositol Phosphates/analysis , Nitric Oxide Synthase/metabolism , Parotid Gland/enzymology , Rats , Rats, Wistar , Receptors, Purinergic P1/metabolism , Xanthines/metabolism
12.
Int Immunopharmacol ; 4(14): 1837-44, 2004 Dec 20.
Article in English | MEDLINE | ID: mdl-15531299

ABSTRACT

The non-obese diabetic (NOD) mouse is chosen among other experimental models to study autoimmune sialadenitis resembling Sjögren's syndrome (SS), because of its unique characteristic of developing salivary dysfunction. Based on the deep loss of nitric oxide synthase (NOS) activity in parotid glands of NOD mice observed from early stages of disease and the inhibitory effect of nitric oxide (NO) donors on amylase secretion in normal salivary glands, our goal was to investigate whether parotid glands from NOD mice lacking NOS activity presented this regulatory mechanism of amylase secretion. We found that parotid glands from NOD mice lack nitric oxide-mediated regulation of amylase secretion in response to VIP stimulation. The lack of regulation might be assigned to the loss of NOS activity as derived from the results with NOS inhibitors and increasing concentrations of VIP. These functional differences observed in NOD vs. BALB/c parotid glands occur in the absence of immune infiltrates in exocrine tissue, and it is not related to cAMP accumulation. NO-mediated regulation of amylase secretion was not observed in BALB/c submandibular glands to the same extent as described in parotid glands and was absent in submandibular glands of NOD mice.


Subject(s)
Amylases/metabolism , Gastrointestinal Agents/pharmacology , Nitric Oxide/physiology , Parotid Gland/metabolism , Vasoactive Intestinal Peptide/pharmacology , Animals , Cyclic AMP/metabolism , Mice , Mice, Inbred BALB C , Mice, Inbred NOD , Nitric Oxide Synthase/metabolism , Parotid Gland/enzymology
13.
Biochem Pharmacol ; 68(9): 1767-74, 2004 Nov 01.
Article in English | MEDLINE | ID: mdl-15450942

ABSTRACT

Experiments were designed to determine whether cannabinoids affect salivary gland function. For this purpose, the effect of anandamide on cAMP accumulation, amylase release and Na+-K+-ATPase activity was studied in rat parotid glands. Anandamide induced a concentration-dependent increase in cAMP and led to amylase release but inhibited Na+-K+-ATPase activity. These effects were blocked by the CB1 cannabinoid receptor antagonist, AM281. The inhibition of adenylyl cyclase activity by SQ 22536 impaired amylase release and Na+-K+-ATPase inhibition. The effect of anandamide on cAMP accumulation significantly correlated with its action either on amylase release or on Na+-K+-ATPase activity. Such correlation strongly supports the view that the effect of anandamide on amylase release and Na+-K+-ATPase activity is the result of cAMP accumulation. The relative potencies of the CB1 cannabinoid receptor antagonist, AM281, to block these three functional responses were similar, supporting the view that anandamide actions in parotid glands were achieved through a single receptor subtype, the CB1. Binding studies using the selective cannabinoid CB1 receptor antagonist, [3H]SR141716A, indicated the presence of the specific binding site. It may be concluded that in parotid glands the endogenous cannabinoid anandamide, bound to the CB1 cannabinoid receptor subtype, induces cAMP accumulation which in turn leads to amylase release and Na+-K+-ATPase inhibition.


Subject(s)
Parotid Gland/metabolism , Receptor, Cannabinoid, CB1/metabolism , Animals , Cyclic AMP/metabolism , Male , Parotid Gland/enzymology , Rats , Rats, Wistar , Sodium-Potassium-Exchanging ATPase/metabolism
14.
Eur J Pharmacol ; 486(1): 99-106, 2004 Feb 13.
Article in English | MEDLINE | ID: mdl-14751414

ABSTRACT

In this study, we investigated the different signalling pathways involved in muscarinic acetylcholine M(3) receptor-dependent modulation of Na(+)-K(+)-ATPase in parotid glands from normal and castrated rats. Carbachol inhibited the enzyme activity in parotid glands from control rats while it stimulated the enzyme activity in castrated rats. The inhibition of Ca(2+) calmodulin by trifluoperazine abolished the inhibitory effect of carbachol in control rats, while the inhibition of protein kinase C by staurosporine stimulated Na(+)-K(+)-ATPase. In castrated rats, trifluoperazine inhibited the carbachol-stimulant effect while staurosporine had no effect. Results indicate that in control glands the activation of a phospholipid-Ca(2+) calmodulin-dependent protein kinase C is responsible for the inhibitory effect of carbachol on Na(+)-K(+)-ATPase activity. In castrated rats, the activation of the enzyme by carbachol is regulated by its Ca(2+) calmodulin-stimulating action, and not by activation of protein kinase C. The activation of the Na(+)-K(+)-ATPase observed in castrated rats resulted in a decrease in carbachol-induced net K(+) efflux and thereby could decrease salivary fluid production.


Subject(s)
Orchiectomy , Parotid Gland/enzymology , Receptor, Muscarinic M3/metabolism , Sodium-Potassium-Exchanging ATPase/metabolism , Animals , Binding Sites , Carbachol/pharmacology , Cholinergic Fibers/drug effects , Cholinergic Fibers/enzymology , Dose-Response Relationship, Drug , Male , Ouabain/metabolism , Parotid Gland/drug effects , Rats , Rats, Wistar , Receptor, Muscarinic M3/agonists , Testosterone/pharmacology
15.
Br J Pharmacol ; 139(2): 399-407, 2003 May.
Article in English | MEDLINE | ID: mdl-12770945

ABSTRACT

1 The mechanism and receptor subtypes involved in carbachol-stimulated amylase release and its changes after castration were studied in parotid slices from male rats. 2 Carbachol induced both amylase release and inositol phosphate (IP) accumulation in parotid slices from control and castrated rats, but castration induced a decrease of carbachol maximal effect. The effect of castration was reverted by testosterone replacement. 3 The selective M(1) and M(3) muscarinic receptor antagonists, pirenzepine and 4-diphenylacetoxy-N-methylpiperidine methiodide, respectively, inhibited carbachol-stimulated amylase release and IP accumulation in a dose-dependent manner in parotid slices from control and castrated rats. 4 A diminution of binding sites of muscarinic receptor in parotid membrane from castrated rats was observed. Competition binding assays showed that both, M(1) and M(3) muscarinic receptor subtypes are expressed in membranes of parotid glands from control and castrated rats, M(3) being the greater population. 5 These results suggest that amylase release induced by carbachol in parotid slices is mediated by phosphoinositide accumulation. This mechanism appears to be triggered by the activation of M(1) and M(3) muscarinic receptor subtypes. Castration induced a decrease of the maximal effect of carbachol evoked amylase release and IP accumulation followed by a diminution in the number of parotid gland muscarinic acetylcholine receptors.


Subject(s)
Amylases/metabolism , Parotid Gland/enzymology , Receptors, Muscarinic/metabolism , Animals , Binding, Competitive , Carbachol/pharmacology , Cholinergic Agonists/pharmacology , Down-Regulation , Inositol Phosphates/metabolism , Male , Orchiectomy , Parotid Gland/drug effects , Parotid Gland/metabolism , Piperidines/pharmacology , Pirenzepine/pharmacology , Rats , Rats, Wistar , Receptor, Muscarinic M1/antagonists & inhibitors , Receptor, Muscarinic M1/metabolism , Receptor, Muscarinic M3/antagonists & inhibitors , Receptor, Muscarinic M3/metabolism
16.
Arch Oral Biol ; 48(2): 101-9, 2003 Feb.
Article in English | MEDLINE | ID: mdl-12642228

ABSTRACT

Carbohydrate metabolism was examined in the developing rat salivary glands by analysing enzymatic activity and glycogen content in the postnatal parotid and submandibular glands. The following enzymes of the carbohydrate metabolism, hexokinase (HK), phosphofructokinase-1 (PFK-1), pyruvate kinase (PK), glucose-6-phosphate dehydrogenase (G6PD), and lactate dehydrogenase (LDH) as well as the content of glycogen were determined in the salivary glands of rats aged 2, 7, 14, 21, 30 and 60 days. The specific activity of HK increased from days 2 to 21 and then it decreased up to 60 days old. The values found for the submandibular glands were from 2.5 to 4.9 times higher than those found for the parotid gland, except for rats aged 60 days. PFK-1 showed a different pattern of variation between the glands. In the submandibular gland there was a statistically significant increase in PFK-1 specific activity from 2 to 30 days of age and then, in the 60 days old group a return to level of the rats aged 2 days. In parotid gland, the specific activity of PFK-1 decreased between 2 and 7 days of age, from 7 to 14 days the specific activity increased markedly and from 14 to 60 days old it gradually decreased. The specific activity of PK followed the same pattern of variation in the submandibular and parotid glands, showing no great variation. The specific activity of LDH decreased from 2 to 60 days old in the submandibular glands. In the parotid glands the mean values for this enzyme were higher for the 2 days old group, and then decreased to remained more or less constant. The potential capacity of the pentose phosphate pathway was greater than that of glycolysis at early ages. The glycogen content showed similar variation in both glands. It was initially high and then decreased. In conclusion, our results on the activities of enzymes involved in carbohydrate metabolism in submandibular and parotid glands may be relevant to the initiation of saliva secretion in these animals.


Subject(s)
Carbohydrate Metabolism , Glycogen/metabolism , Parotid Gland/metabolism , Submandibular Gland/metabolism , Animals , Glucosephosphate Dehydrogenase/metabolism , Hexokinase/metabolism , L-Lactate Dehydrogenase/metabolism , Parotid Gland/enzymology , Parotid Gland/growth & development , Phosphofructokinase-1/metabolism , Pyruvate Kinase/metabolism , Rats , Rats, Wistar , Submandibular Gland/enzymology , Submandibular Gland/growth & development
17.
Arch Oral Biol ; 47(10): 717-22, 2002 Oct.
Article in English | MEDLINE | ID: mdl-12356503

ABSTRACT

It is not known whether the mechanisms involved in amylase release in submandibular and parotid glands are similar. Here, the participation of different signalling pathways in amylase release by the parotid and submandibular glands of the male rat was compared by studying the secretory response after beta-adrenergic stimulation. The beta-adrenergic agonist isoproterenol induced an increase of cAMP in both salivary glands, but while in the parotid it triggered amylase release, in the submandibular it was unable to increase amylase secretion. Parotid amylase release was dependent on adenylate cyclase activation, as SQ-22536 inhibited the secretory effect. In contrast, submandibular amylase secretion did not depend on the intracellular concentration of cAMP, as SQ-22536 did not modify its secretory response. Moreover, other activators of adenylate cyclase, such as forskolin and prostaglandin E2, also failed to modify amylase release by the submandibular gland. Neither ionophores nor calcium-blocking agents, as well as calcium-calmodulin and nitric oxide synthase inhibitors, were effective in modifying basal amylase release by the submandibular gland. However, the disruption of microfilaments with cytochalasin B, but not the disruption of microtubules with colchicine, prevented amylase release in that gland. It is concluded that amylase exocytosis in the submandibular gland is a constitutive non-regulated phenomenon, as it is independent of extracellular or intracellular signals. It depends only on the integrity of the microfilaments, probably used by the vesicles to travel from the Golgi apparatus to the plasma membrane.


Subject(s)
Adenine/analogs & derivatives , Amylases/metabolism , Parotid Gland/metabolism , Signal Transduction , Submandibular Gland/metabolism , Actin Cytoskeleton/drug effects , Adenine/pharmacology , Adenylyl Cyclases/metabolism , Adrenergic beta-Agonists/pharmacology , Animals , Cyclic AMP/metabolism , Cytochalasin B/pharmacology , Enzyme Activation , Isoproterenol/pharmacology , Male , Organ Culture Techniques , Parotid Gland/enzymology , Parotid Gland/ultrastructure , Rats , Rats, Wistar , Signal Transduction/drug effects , Submandibular Gland/enzymology , Submandibular Gland/ultrastructure
18.
Clin Immunol ; 101(1): 86-93, 2001 Oct.
Article in English | MEDLINE | ID: mdl-11580230

ABSTRACT

The non-obese diabetic (NOD) mouse model of autoimmune sialadenitis offers the possibility of studying the L-arginine/nitric oxide signaling pathway in salivary glands in basal and neurotransmitter-stimulated conditions and, thus, of analyzing the neural control of the secretory process in the target organ. The purpose of this study was to explore putative alterations in the activity and expression of nitric oxide synthase (NOS) in submandibular glands of NOD mice in relation to parotid glands and unrelated tissues. Here we report that NOD mice with incipient signs of secretory dysfunction presented a marked decrease in basal and vasoactive intestinal peptide (VIP)-stimulated NOS activity and a differential expression of NOS I in submandibular glands compared to control BALB/c mice. Similar alterations in NOS I were found in parotid glands but not in brain or spleen of NOD mice. No differences between NOD and controls appeared in NOS II and NOS III expression in any of the tissues studied.


Subject(s)
Nitric Oxide Synthase/metabolism , Sialadenitis/enzymology , Sjogren's Syndrome/enzymology , Submandibular Gland/enzymology , Amylases/metabolism , Animals , Culture Techniques , Female , Mice , Mice, Inbred BALB C , Mice, Inbred NOD , Nitric Oxide Synthase Type I , Parotid Gland/enzymology , Protein Isoforms/metabolism , Saliva/enzymology , Saliva/physiology , Submandibular Gland/drug effects , Submandibular Gland/metabolism , Vasoactive Intestinal Peptide/pharmacology
19.
Biochem Biophys Res Commun ; 247(1): 123-8, 1998 Jun 09.
Article in English | MEDLINE | ID: mdl-9636666

ABSTRACT

In previous in vivo studies we have reported that atrial natriuretic factor enhanced induced salivary secretion and increased isoproterenol-induced amylase release in the rat suggesting that, ANF effect could be mediated by phosphatidylinositol hydrolysis. In the present work, the effect of ANF on rat parotid tissue incubated in vitro was investigated with the aim to assess whether the phosphoinositol pathway was involved in ANF intracellular signaling in the parotid gland. Results showed that ANF induced a dose dependent increase in amylase fractional release, which was lower than that evoked by any concentration of isoproterenol. Furthermore 100 nM ANF enhanced isoproterenol-evoked amylase release. The effect of ANF was not affected in the presence of propranolol suggesting the noninvolvement of the beta adrenergic receptor, which is the main stimulus for the output of the enzyme in the parotid gland. However, ANF increased phosphatidylinositol hydrolysis, which implies an increase in intracellular calcium, which is necessary for the achievement of maximal response in amylase release. This effect was abolished in the presence of neomycin supporting ANF direct stimulation of phospholipase C. These results suggest the involvement of the C type natriuretic peptide receptor coupled to phospholipase C in ANF evoked amylase release and ANF enhancement of the isoproterenol-induced output of the enzyme.


Subject(s)
Amylases/metabolism , Atrial Natriuretic Factor/physiology , Inositol Phosphates/physiology , Parotid Gland/enzymology , Adrenergic beta-Agonists/pharmacology , Amylases/drug effects , Animals , Cyclic GMP/analogs & derivatives , Cyclic GMP/pharmacology , Drug Synergism , Isoproterenol/pharmacology , Male , Parotid Gland/drug effects , Phosphatidylinositols/metabolism , Propranolol/pharmacology , Rats , Rats, Wistar
20.
Bauru; s.n; 1996. 166 p. ilus, tab, graf.
Thesis in Portuguese | LILACS, BBO - Dentistry | ID: lil-250833

ABSTRACT

A fosfatase ácida de BPM da parótida bovina foi purificada 1.800 vezes até a homogeneidade, com rendimento de 8 por cento, através de um procedimento envolvendo fracionamento com sulfato de amônio, tratamento ácido e cromatografia de troca iônica em SP-Sephadex com eluiçäo por íon-afinidade. Os critérios de pureza utilizados foram a A.E., PAGE, SDS-PAGE, filtraçäo em gel (Superdex HR 70) e análise da composiçäo de aminoácidos. A enzima purificada (A.E. de 100 µmol min-1 mg-1) é composta por uma cadeia polipeptídica simples e possui Mr de 13,6 e 19 kDa, como determinado através da filtraçäo em gel e SDS-PAGE, respectivamente. A composiçäo parcial de aminoácidos (Cys e Trp näo foram determinados) foi obtida após a hidrólise ácida da proteína purificada seguida da análise dos resíduos de aminoácidos e evidenciou a existência de, pelo menos, 151 resíduos de aminoácidos...


Subject(s)
Animals , Male , Female , Cattle , Acid Phosphatase/metabolism , Parotid Gland/enzymology , Acid Phosphatase/pharmacokinetics , Parotid Gland/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL